Vaccines and Guillain-Barre syndrome

被引:0
|
作者
Hughes, R
Rees, J
Smeeton, N
Winer, J
机构
[1] GUYS HOSP,DEPT PUBL HLTH MED,LONDON,ENGLAND
[2] QUEEN ELIZABETH HOSP,BIRMINGHAM B29 6JD,W MIDLANDS,ENGLAND
来源
BRITISH MEDICAL JOURNAL | 1996年 / 312卷 / 7044期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1475 / 1476
页数:2
相关论文
共 50 条
  • [1] Vaccines and Guillain-Barre Syndrome
    Haber, Penina
    Sejvar, James
    Mikaeloff, Yann
    DeStefan, Frank
    DRUG SAFETY, 2009, 32 (04) : 309 - 323
  • [3] VACCINES, POLIOMYELITIS, AND GUILLAIN-BARRE SYNDROME
    ABRAMSON, HA
    JOURNAL OF ASTHMA RESEARCH, 1976, 14 (01): : 1 - 4
  • [4] Vaccines and the risk of Guillain-Barre syndrome
    Chen, Yong
    Zhang, Jinlin
    Chu, Xuhua
    Xu, Yuanling
    Ma, Fubao
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2020, 35 (04) : 363 - 370
  • [5] Influenza vaccines and Guillain-Barre syndrome The continuing question
    Sejvar, James J.
    NEUROLOGY, 2013, 81 (18) : 1562 - 1563
  • [6] Guillain-Barre syndrome and influenza vaccines: current evidence
    Sanz Fadrique, Rosario
    Arias, Luis Martin
    Arcadio Molina-Guarneros, Juan
    Jimeno Bulnes, Natalia
    Garcia Ortega, Pilar
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2019, 32 (04) : 288 - 295
  • [7] Guillain-Barre Syndrome: The role of influenza vaccines and infection
    Kurland, LT
    Wiederholt, WC
    Beghi, E
    Kirkpatrick, JW
    BRAIN PATHOLOGY, 1997, 7 (04) : 1195 - 1195
  • [8] Guillain-Barre syndrome associated with vaccines in Veracruz, Mexico
    Del Carpio-Orantes, Luis
    Solis-Sanchez, Ishar
    Piquet-Uscanga, Yuri Omar
    Moreno-Aldama, Nancy Patricia
    Aguilar-Silva, Andres
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [9] Guillain-Barre syndrome associated with vaccines in Veracruz, Mexico
    Del Carpio-Orantes, Luis
    Solis-Sanchez, Ishar
    Omar Piquet-Uscanga, Yuri
    BRAIN CIRCULATION, 2022, 8 (03) : 165 - 167
  • [10] Guillain-Barre Syndrome and Influenza Vaccines: Croatian Experience
    Krnic, D.
    Andric, A.
    Sarinic, V. Macolic
    DRUG SAFETY, 2013, 36 (09) : 936 - 937